Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,201,927
  • Shares Outstanding, K 52,463
  • Annual Sales, $ 408,900 K
  • Annual Income, $ 110,990 K
  • 60-Month Beta 1.53
  • Price/Sales 2.96
  • Price/Cash Flow 9.39
  • Price/Book 2.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.57
  • Number of Estimates 4
  • High Estimate 0.59
  • Low Estimate 0.54
  • Prior Year 0.48
  • Growth Rate Est. (year over year) +18.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.35 +16.51%
on 11/06/19
23.60 -4.47%
on 11/29/19
-6.58 (-22.61%)
since 11/05/19
3-Month
19.35 +16.51%
on 11/06/19
29.81 -24.37%
on 09/19/19
-5.07 (-18.34%)
since 09/05/19
52-Week
19.35 +16.51%
on 11/06/19
43.05 -47.63%
on 02/27/19
-23.46 (-51.00%)
since 12/04/18

Most Recent Stories

More News
Look for Shares of Supernus Pharmac to Potentially Pullback after Yesterday's 2.82% Rise

Supernus Pharmac (NASDAQ:SUPN) traded in a range yesterday that spanned from a low of $22.77 to a high of $23.50. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high...

SUPN : 22.56 (-1.53%)
Supernus to Present at Two November Healthcare Conferences

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that...

SUPN : 22.56 (-1.53%)
Supernus Submits New Drug Application for SPN-812 for the Treatment of ADHD

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that...

SUPN : 22.56 (-1.53%)
Shares of Supernus Pharmac Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (SUPN , NKTR , BMY , PCRX , JNJ )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

BMY : 59.30 (+0.68%)
NKTR : 20.04 (-1.28%)
SUPN : 22.56 (-1.53%)
Watch for Supernus Pharmac to Potentially Rebound After Falling 20.39% Yesterday

Supernus Pharmac (NASDAQ:SUPN) traded in a range yesterday that spanned from a low of $20.01 to a high of $22.00. Yesterday, the shares fell 20.4%, which took the trading range below the 3-day low of...

SUPN : 22.56 (-1.53%)
Intra-Cellular T has the Best Relative Performance in the Pharmaceuticals Industry (ITCI , SUPN , MDCO , PRGO , CTLT )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

ITCI : 9.82 (-1.60%)
MDCO : 84.11 (+0.05%)
SUPN : 22.56 (-1.53%)
Supernus Pharmaceuticals (SUPN) Q3 Earnings and Revenues Lag Estimates

Supernus (SUPN) delivered earnings and revenue surprises of -8.47% and -6.51%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

SUPN : 22.56 (-1.53%)
Supernus: 3Q Earnings Snapshot

ROCKVILLE, Md. (AP) _ Supernus Pharmaceuticals Inc. (SUPN) on Tuesday reported third-quarter earnings of $28.9 million.

SUPN : 22.56 (-1.53%)
Supernus Announces Third Quarter 2019 Financial Results and Topline Data from Phase III Study of SPN-810 for Treatment of Impulsive Aggression (IA) in ADHD Patients

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today reported financial...

SUPN : 22.56 (-1.53%)
Supernus to Host Third Quarter 2019 Earnings Conference Call

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that...

SUPN : 22.56 (-1.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade SUPN with:

Business Summary

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit...

See More

Key Turning Points

2nd Resistance Point 23.55
1st Resistance Point 23.23
Last Price 22.56
1st Support Level 22.55
2nd Support Level 22.19

See More

52-Week High 43.05
Fibonacci 61.8% 34.00
Fibonacci 50% 31.20
Fibonacci 38.2% 28.40
Last Price 22.56
52-Week Low 19.35

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar